Suvanza Pharma, LLC (SUVZ)
OTCMKTS
· Delayed Price · Currency is USD
0.0002
0.00 (0.00%)
At close: Apr 23, 2026
Suvanza Pharma, LLC Company Description
Suvanza Pharma, LLC operates as an early-stage biotechnology corporation and engages in the development of the skin drug delivery system, RapiDerm for dermatologic diseases.
Suvanza Pharma, LLC was formerly known as Hamilton PNG and changed its name to Suvanza Pharma, LLC in March 2010.
The company was founded in 2004 and is based in Miami Beach, Florida.
Suvanza Pharma, LLC
| Country | United States |
| Founded | 2004 |
| Industry | Biotechnology |
| Sector | Healthcare |
| CEO | Nardo Zaias |
Contact Details
Address: 5401 Collins Avenue Miami Beach, Florida 33140 United States | |
| Phone | 866-633-9546 |
| Website | suvanza.com |
Stock Details
| Ticker Symbol | SUVZ |
| Exchange | OTCMKTS |
| Reporting Currency | USD |
| ISIN Number | US8695511019 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Dr. Nardo Zaias M.D. | Interim Chief Executive Officer, President and Director |
| Dr. Manuel Zaiac Dr Juris, CPA | Interim Chief Financial Officer |
| Magaly Fast | Treasurer and Director |
| Ed Iaconis | Interim Secretary |